E VBI Vaccines: Hidden Vaccine Gem

Takeaway

The key investor takeaway is that VBI Vaccines has a major catalyst with the startup of Phase III trials for Sci-B-Vac. The recent inclusion in the Russell 2000 should garner the stock more attention after previously flying below the radar. The path to the Phase III trials provides the alert investor an opportunity to invest in a stock that didn't have the typical run-up following the normal process of releasing positive Phase II results. 

As with any small biotech, an investment is only recommended for a small portion of a diversified portfolio.

1 2 3 4
View single page >> |

Disclosure: No position. 

Additional disclosure: Please consult your financial advisor before making any investment decisions.

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Grayson Brown 2 years ago Member's comment

Cool. This is a very informative article which deserves a better publicity. I would like to see how their Phase III trials go. Probably a good time to buy and hold. Maybe? $VBIV

Samuel Kaufman 2 years ago Member's comment

I have been an investing veteran of #pharma companies for years. For the first time, I am truely amazed by the scale of the trials #VBI has been conducting. $VBIV

Bill Johnson 2 years ago Member's comment

Grayson Brown and Samuel Kaufman, you left very similar comments at the same time. Same person perhaps trying to pump up this stock? $VBIV